Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: identification of alleles associated with fatal and nonfatal disease outcomes.
about
Human Leukocyte Antigen Diversity: A Southern African PerspectiveFiloviruses: One of These Things is (not) Like the OtherAddressing Therapeutic Options for Ebola Virus Infection in Current and Future OutbreaksEbola: a holistic approach is required to achieve effective management and controlMouse models for filovirus infectionsStructural basis for Marburg virus VP35-mediated immune evasion mechanismsNovel Chemical Ligands to Ebola Virus and Marburg Virus Nucleoproteins Identified by Combining Affinity Mass Spectrometry and Metabolomics ApproachesHigh-throughput high-resolution class I HLA genotyping in East Africa.Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.Biomarker correlates of survival in pediatric patients with Ebola virus disease.A novel single cDNA amplicon pyrosequencing method for high-throughput, cost-effective sequence-based HLA class I genotyping.Effects of Mother's Illness and Breastfeeding on Risk of Ebola Virus Disease in a Cohort of Very Young ChildrenProgress in filovirus vaccine development: evaluating the potential for clinical use.An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions.New paradigms in sepsis: from prevention to protection of failing microcirculation.Correlates of immunity to filovirus infection.Animal models for ebolavirus countermeasures discovery: what defines a useful model?Ebola Virus Disease in Humans: Pathophysiology and Immunity.RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor.Assays to Measure Suppression of Type I Interferon Responses by Filovirus VP35 Proteins.Nonhuman primates as models for the discovery and development of ebolavirus therapeutics.Exploring the mechanism how Marburg virus VP35 recognizes and binds dsRNA by molecular dynamics simulations and free energy calculations.
P2860
Q26782686-295FF277-9671-4F78-B0C8-7BEF0265434DQ26783063-1727429B-B203-4923-A9A9-C4DCF0E547D9Q26801423-C0B9AEFD-5B81-4375-9BAD-2DEF9B875A67Q26823792-A0308CAA-4186-4DF8-B83F-3AB90282FB85Q27011569-44789E36-A037-45F6-A980-55D5F5FD2C35Q27675266-8108C483-B045-478E-A69A-9154CD8A7652Q28830618-F6C598C4-46A6-48F5-AAE4-CE83A43734D1Q33588595-9573E02A-C211-4C26-8623-B8758916091CQ34229715-F2746A3E-94F8-435A-96E1-5829A99FA44EQ34320456-72D9ADF3-2CB0-4BFC-9665-1B32074F976DQ35321693-5C374066-2C61-41B1-8F4E-AA6A37426638Q35983617-7DF62A7A-39F4-4FDE-9588-0DB84801F1AEQ36100545-7B57457B-63BE-4106-AF6E-53B72F69066BQ36141181-0B483CD3-E7F0-496D-B8EA-C5DE5858D27EQ37238202-8A329014-6F2D-4ECA-ADA1-E1759EEA0E7BQ37945233-9EC1173E-371D-450C-B436-4EEC2B526EEBQ38500788-EAE315AD-84BD-4FB4-AC52-5304DAC23C19Q38707770-21077558-CF57-4171-AACC-0728BDD7AB2AQ38857149-E2A6EEF5-A68D-495C-9B85-958A6390D5B9Q40054495-46D21CAD-98E1-497A-8B07-13A51D4BCAB7Q40332893-8A90A356-535C-4408-97B2-A9BB375F8E09Q42231570-B92F3A9C-D8BF-421C-AE6E-94C73CC63B95
P2860
Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: identification of alleles associated with fatal and nonfatal disease outcomes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Sequence-based human leukocyte ...... and nonfatal disease outcomes.
@en
type
label
Sequence-based human leukocyte ...... and nonfatal disease outcomes.
@en
prefLabel
Sequence-based human leukocyte ...... and nonfatal disease outcomes.
@en
P2860
P921
P356
P1476
Sequence-based human leukocyte ...... and nonfatal disease outcomes.
@en
P2093
Anthony Sanchez
Kent E Wagoner
P2860
P304
P356
10.1086/520588
P407
P478
196 Suppl 2
P577
2007-11-01T00:00:00Z